Neoadjuvant Safety of Sintilimab + XELOX + Bevacizumab in PMMR/MSS CRLM Patients
Clinical trial NCT04940546 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04940546
- Sponsor
- Sun Yat-sen University
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-16
- Primary completion
- 2023-10-30
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.